Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $169,512 (100.0% shares, 0.0% debt)

Holdings (29)

— SAGE THERAPEUTICS INC 10.7%

Value ($000) $18,123 Shares 255,000 Est. Cost $47.85 Unrealized —

— FOUNDATION MEDICINE INC 9.1%

Value ($000) $15,480 Shares 480,000 Est. Cost $18.96 Unrealized —

— LOXO ONCOLOGY INC 8.9%

Value ($000) $15,149 Shares 360,000 Est. Cost $28.44 Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 8.2%

Value ($000) $13,870 Shares 237,500 Est. Cost $51.75 Unrealized -7.4%

— BLUEPRINT MEDICINES CORP 6.9%

Value ($000) $11,777 Shares 294,500 Est. Cost $28.38 Unrealized —

EVH EVOLENT HEALTH INC 6.8%

Value ($000) $11,596 Shares 520,000 Est. Cost $18.09 Unrealized +6.1%

— EPIZYME INC 4.9%

Value ($000) $8,318 Shares 485,000 Est. Cost $15.65 Unrealized —

— SPARK THERAPEUTICS INC 4.2%

Value ($000) $7,201 Shares 135,000 Est. Cost $45.28 Unrealized —

VYGR VOYAGER THERAPEUTICS INC 3.9%

Value ($000) $6,620 Shares 500,000 Est. Cost $15.72 Unrealized —

— GENMARK DIAGNOSTICS INC 3.0%

Value ($000) $5,128 Shares 400,000 Est. Cost $9.74 Unrealized —

— AUDENTES THERAPEUTICS INC 2.6%

Value ($000) $4,430 Shares 260,000 Est. Cost $17.04 Unrealized —

SGMO SANGAMO THERAPEUTICS INC 2.6%

Value ($000) $4,420 Shares 850,000 Est. Cost $4.01 Unrealized 0.0%

MDRX ALLSCRIPTS HEALTHCARE SOLUTN 2.3%

Value ($000) $3,931 Shares 310,000 Est. Cost $12.72 Unrealized -6.8%

— GLOBAL BLOOD THERAPEUTICS IN 2.2%

Value ($000) $3,740 Shares 101,500 Est. Cost $17.96 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 2.1%

Value ($000) $3,619 Shares 700,000 Est. Cost $4.89 Unrealized 0.0%

— MYOKARDIA INC 2.1%

Value ($000) $3,485 Shares 265,000 Est. Cost $13.62 Unrealized —

— KITE PHARMA INC 2.0%

Value ($000) $3,336 Shares 42,500 Est. Cost $52.57 Unrealized —

CDXS CODEXIS INC 1.9%

Value ($000) $3,240 Shares 675,000 Est. Cost $4.56 Unrealized 0.0%

— AMYRIS INC 1.9%

Value ($000) $3,180 Shares 6,000,000 Est. Cost $0.64 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 1.8%

Value ($000) $3,065 Shares 177,500 Est. Cost $15.07 Unrealized -12.7%

EDIT EDITAS MEDICINE INC 1.8%

Value ($000) $2,976 Shares 133,333 Est. Cost $20.61 Unrealized +0.6%

— SYROS PHARMACEUTICALS INC 1.7%

Value ($000) $2,902 Shares 182,141 Est. Cost $13.81 Unrealized —

— JOUNCE THERAPEUTICS INC 1.7%

Value ($000) $2,859 Shares 130,000 Est. Cost $21.99 Unrealized —

ALNY ALNYLAM PHARMACEUTICALS INC 1.7%

Value ($000) $2,819 Shares 55,000 Est. Cost $61.19 Unrealized -24.5%

— TESARO INC 1.6%

Value ($000) $2,693 Shares 17,500 Est. Cost $153.89 Unrealized —

— BLUEBIRD BIO INC 1.4%

Value ($000) $2,318 Shares 25,500 Est. Cost $60.64 Unrealized —

— CLOVIS ONCOLOGY INC 0.9%

Value ($000) $1,464 Shares 23,000 Est. Cost $63.65 Unrealized —

— ADVERUM BIOTECHNOLOGIES INC 0.7%

Value ($000) $1,134 Shares 420,000 Est. Cost $2.70 Unrealized —

— CURIS INC 0.4%

Value ($000) $639 Shares 230,000 Est. Cost $2.78 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SAGE THERAPEUTICS INC	255,000	$18,123	10.7%	$47.85	—	COM	78667J108
—	FOUNDATION MEDICINE INC	480,000	$15,480	9.1%	$18.96	—	COM	350465100
—	LOXO ONCOLOGY INC	360,000	$15,149	8.9%	$28.44	—	COM	548862101
AGIO	AGIOS PHARMACEUTICALS INC	237,500	$13,870	8.2%	$51.75	-7.4%	COM	00847X104
—	BLUEPRINT MEDICINES CORP	294,500	$11,777	6.9%	$28.38	—	COM	09627Y109
EVH	EVOLENT HEALTH INC	520,000	$11,596	6.8%	$18.09	+6.1%	CL A	30050B101
—	EPIZYME INC	485,000	$8,318	4.9%	$15.65	—	COM	29428V104
—	SPARK THERAPEUTICS INC	135,000	$7,201	4.2%	$45.28	—	COM	84652J103
VYGR	VOYAGER THERAPEUTICS INC	500,000	$6,620	3.9%	$15.72	—	COM	92915B106
—	GENMARK DIAGNOSTICS INC	400,000	$5,128	3.0%	$9.74	—	COM	372309104
—	AUDENTES THERAPEUTICS INC	260,000	$4,430	2.6%	$17.04	—	COM	05070R104
SGMO	SANGAMO THERAPEUTICS INC	850,000	$4,420	2.6%	$4.01	0.0%	COM	800677106
MDRX	ALLSCRIPTS HEALTHCARE SOLUTN	310,000	$3,931	2.3%	$12.72	-6.8%	COM	01988P108
—	GLOBAL BLOOD THERAPEUTICS IN	101,500	$3,740	2.2%	$17.96	—	COM	37890U108
PACB	PACIFIC BIOSCIENCES CALIF IN	700,000	$3,619	2.1%	$4.89	0.0%	COM	69404D108
—	MYOKARDIA INC	265,000	$3,485	2.1%	$13.62	—	COM	62857M105
—	KITE PHARMA INC	42,500	$3,336	2.0%	$52.57	—	COM	49803L109
CDXS	CODEXIS INC	675,000	$3,240	1.9%	$4.56	0.0%	COM	192005106
—	AMYRIS INC	6,000,000	$3,180	1.9%	$0.64	—	COM	03236M101
CTMX	CYTOMX THERAPEUTICS INC	177,500	$3,065	1.8%	$15.07	-12.7%	COM	23284F105
EDIT	EDITAS MEDICINE INC	133,333	$2,976	1.8%	$20.61	+0.6%	COM	28106W103
—	SYROS PHARMACEUTICALS INC	182,141	$2,902	1.7%	$13.81	—	COM	87184Q107
—	JOUNCE THERAPEUTICS INC	130,000	$2,859	1.7%	$21.99	—	COM	481116101
ALNY	ALNYLAM PHARMACEUTICALS INC	55,000	$2,819	1.7%	$61.19	-24.5%	COM	02043Q107
—	TESARO INC	17,500	$2,693	1.6%	$153.89	—	COM	881569107
—	BLUEBIRD BIO INC	25,500	$2,318	1.4%	$60.64	—	COM	09609G100
—	CLOVIS ONCOLOGY INC	23,000	$1,464	0.9%	$63.65	—	COM	189464100
—	ADVERUM BIOTECHNOLOGIES INC	420,000	$1,134	0.7%	$2.70	—	COM	00773U108
—	CURIS INC	230,000	$639	0.4%	$2.78	—	COM	231269101